Filament BioSolutions

New York, United States Founded: 2013 • Age: 13 yrs
Therapeutics and medical foods are developed for various diseases.
Request Access

About Filament BioSolutions

Filament BioSolutions is a company based in New York (United States) founded in 2013.. Filament BioSolutions operates in a competitive market with competitors including Uute Scientific, WellGen, Labormed, Glycemicon and Ambra Bio, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Filament BioSolutions

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2016 Amount Series C - Filament BioSolutions Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Filament BioSolutions

Filament BioSolutions has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ajinomoto. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Multi-category food and beverage products are manufactured globally.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Filament BioSolutions

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Filament BioSolutions

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Filament Biosolutions Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Filament BioSolutions

Filament BioSolutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Uute Scientific, WellGen, Labormed, Glycemicon and Ambra Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Natural extract products for immune-mediated diseases are provided.
domain founded_year HQ Location
Medical foods are developed using nutrigenomics and bioinformatics models.
domain founded_year HQ Location
Manufacturer of pharmaceuticals and food supplements
domain founded_year HQ Location
Online store offering chemicals, lab supplies, and glassware for research.
domain founded_year HQ Location
Developer of dietary supplements and medical foods
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Filament Biosolutions

Frequently Asked Questions about Filament BioSolutions

When was Filament BioSolutions founded?

Filament BioSolutions was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Where is Filament BioSolutions located?

Filament BioSolutions is headquartered in New York, United States. It is registered at New York, New York, United States.

What does Filament BioSolutions do?

Developer of therapeutics and medical foods for a wide range of diseases. The companys lead product is FB-2710 FB-2710, an oral, proprietary formulation of an optimal analog of glutamine, treat Oral Mucositis. The company recently announced a partnership with Ajinomoto to develop a portfolio of evidence-based medical foods and an exclusive license agreement with leading academic institutions for the beverage to prevent kidney stones.

Who are the top competitors of Filament BioSolutions?

Filament BioSolutions's top competitors include Uute Scientific, Ambra Bio and WellGen.

Who are Filament BioSolutions's investors?

Filament BioSolutions has 1 investor. Key investors include Ajinomoto.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available